Background: We compared overall survival (OS) between radiation therapy (RT) and chemoradiotherapy (CRT) in patients with anaplastic thyroid carcinoma (ATC) using a large database.
Methods: The National Cancer Data Base was queried for ATC patients diagnosed between 2004 and 2013 who received RT or CRT. Groups were balanced by propensity score matching (PSM) on nine relevant variables. OS was also examined in five paired subgroups given known patient heterogeneity.
Results: Of 858 total patients, 575 received CRT and 283 received RT. CRT was associated with decreased risk of death (hazard ratio [HR] 0.66, P < .001), 1-year OS 25.5% vs 14.3%. A survival advantage to CRT was seen using PSM cohorts (HR 0.75, P = .006). Those receiving definitive surgery saw the greatest benefit to CRT over RT (HR 0.65, P = .009), 1-year OS 39.6% vs 20.4%.
Conclusions: CRT is associated with decreased risk of death in ATC; the magnitude of CRT vs RT benefit varied by subgroup.
Keywords: anaplastic thyroid carcinoma; chemoradiation; chemotherapy; national cancer data base; radiation therapy.
© 2019 Wiley Periodicals, Inc.
Conflict of interest statement
CONFLICT OF INTEREST
K.A.H. is a Consultant at Astra Zeneca, Varian Medical Systems; advisory boards: Astra Zeneca, Genetech; Industry funded research: RefleXion Medical.
Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1100-1110. doi: 10.1001/jamaoto.2016.2168. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27541166
Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.Cancer. 2016 May 15;122(10):1533-43. doi: 10.1002/cncr.29956. Epub 2016 Mar 11. Cancer. 2016. PMID: 26969811
Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.Gynecol Oncol. 2017 Sep;146(3):572-579. doi: 10.1016/j.ygyno.2017.06.022. Epub 2017 Jun 27. Gynecol Oncol. 2017. PMID: 28662775
The addition of chemotherapy in the definitive management of high risk prostate cancer.Urol Oncol. 2018 Nov;36(11):475-487. doi: 10.1016/j.urolonc.2018.07.020. Epub 2018 Oct 9. Urol Oncol. 2018. PMID: 30309766 Free PMC article. Review.
Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis.Eur J Cancer. 2015 Aug;51(12):1570-9. doi: 10.1016/j.ejca.2015.04.027. Epub 2015 Jun 1. Eur J Cancer. 2015. PMID: 26044925 Review.